Immune phenotype of peripheral blood cells and skin squamous cell carcinoma in organ transplant recipients

Expert Review of Clinical Immunology

Volumn 6, Issue 3, 2010, Pages 359-362

  Dziunycz, Piotr ^a   Hofbauer, Günther F L ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Immunosuppression; Inflammatory infiltrate; Regulatory T cells; Squamous cell carcinoma

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CD56 ANTIGEN; CD8 ANTIGEN; IMMUNOMODULATING AGENT; PREDNISONE; STEROID;

BLOOD; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; GRAFT RECIPIENT; HUMAN; IMMUNITY; IMMUNOMODULATION; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; NATURAL KILLER T CELL; NOTE; PHENOTYPE; PROSPECTIVE STUDY; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; KILLER CELLS, NATURAL; MALE; PHENOTYPE; POSTOPERATIVE COMPLICATIONS; SKIN NEOPLASMS; T-LYMPHOCYTES, REGULATORY;

EID: 77952023126     PISSN: 1744666X     EISSN: None     Source Type: Journal    
DOI: 10.1586/eci.10.21     Document Type: Note

References (11)

1. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N. Engl. J. Med. 348 (17), 1681-1691 (2003).
2. Ramsay HM, Reece SM, Fryer AA, Smith AG, Harden PN. Seven-year prospective study of nonmelanoma skin cancer incidence in U. K. renal transplant recipients. Transplantation 84 (3), 437-439 (2007).
3. Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J. Am. Acad. Dermatol. 47 (1), 1-17;
4. quiz 18-20 (2002).
5. Jorizzo JL. Current and novel treatment options for actinic keratosis. J. Cutan. Med. Surg. 8 (Suppl. 3), 13-21 (2004).
6. Bui JD, Schreiber RD. Cancer immunosurveillance, immunoediting and infammation: independent or interdependent processes? Curr. Opin. Immunol. 19 (2), 203-208 (2007).
7. Carroll RP, Segundo DS, Hollowood K et al. Immune phenotype predicts risk for posttransplantation squamous cell carcinoma. J. Am. Soc. Nephrol. 21, 713-722 (2010).
8. Klonowski KD, Marzo AL, Williams KJ, Lee SJ, Pham QM, Lefrancois L. CD8 T cell recall responses are regulated by the tissue tropism of the memory cell and pathogen. J. Immunol. 177 (10), 6738-6746 (2006).
9. Muehleisen B, Schaerer L, Dummer R, Burg G, Hofbauer GF. Cancer/testis antigen MAGE-A4 expression pattern differs in epithelial skin tumors of organ-transplant recipients and immunocompetent patients. J. Cutan. Pathol. 34 (1), 1-6 (2007).
10. + cells in the perineoplastic infammatory infltrate. Histopathology 55 (1), 67-76 (2009).
11. Kosmidis M, Dziunycz P, Suarez-Farinas M et al. Immunosuppression affects CD4+ mRNA expression and induces Th2 dominance in the microenvironment of cutaneous squamous cell carcinoma in organ transplant recipients. J. Immunother. (In Press) (2010).